Home › Funds › DAFNA Capital Management LLC › NKTR

DAFNA Capital Management LLC position in NKTR

NEKTAR THERAPEUTICS COM NEW · Health Care

DAFNA Capital Management LLC reported holding 318,380 shares of NKTR (NEKTAR THERAPEUTICS COM NEW) in its Q2 2026 13F filing — a position valued at US$22.2M, representing 4.24% of its reported portfolio and ranking #5 among its reported holdings. DAFNA Capital Management LLC has disclosed NKTR holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

Latest position (Q2 2026)318.38K sh
Reported value held$22.23M
Portfolio Weight4.24%
First reportedQ2 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How DAFNA Capital Management LLC's NKTR position evolved

DAFNA Capital Management LLC first disclosed a stake in NKTR in Q2 2025 at 10,000 shares (US$258K). The position peaked in Q2 2026 at 318,380 shares, worth US$22.2M. Across 5 filings, DAFNA Capital Management LLC increased the stake 4 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 318,380 shares valued at US$22.2M — an increase of 153,202 shares quarter over quarter.. Notable position changes include a 450% increase in Q3 2025 (shares fell 26% over the following quarter), a 120% increase in Q1 2026 (shares fell 3% over the following quarter), a 93% increase in Q2 2026 (shares fell 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 10.00K $258.40K New
Q3 2025 55.00K $3.13M Add
Q4 2025 75.00K $3.17M Add
Q1 2026 165.18K $11.88M Add
Q2 2026 318.38K $22.23M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NKTR and 13F data

NKTR (NEKTAR THERAPEUTICS COM NEW) is a Health Care company. 70 other funds we track also report a position in NKTR — the largest reported positions include Two Seas Capital LP (US$202.6M), BVF INC/IL (US$166.9M), Vestal Point Capital, LP (US$69.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NKTR

All NKTR fund holders →

FAQ

How long has DAFNA Capital Management LLC held NKTR?

DAFNA Capital Management LLC has disclosed NKTR holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

What is DAFNA Capital Management LLC's current position in NKTR?

As of Q2 2026, DAFNA Capital Management LLC holds 318.38K shares of NKTR (NEKTAR THERAPEUTICS COM NEW), valued at $22.23M, representing 4.24% of its reported portfolio and ranking #5.

Has DAFNA Capital Management LLC been buying or selling NKTR?

In the latest 13F filing (Q2 2026), DAFNA Capital Management LLC increased its position in NKTR. The position peaked in Q2 2026 at 318.38K shares.

Which other funds hold NKTR?

Other major institutional holders of NKTR include Two Seas Capital LP, BVF INC/IL, Vestal Point Capital, LP, among 70 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.